Researchers led by Osaka University's Masaki Mori looked into whether miR-146a, a microRNA suspected to be a tumor suppressor in pancreatic, breast, and prostate cancers, also has a role in gastric cancer. The researchers used qPCR to determine the levels of miR-146a present in 90 gastric cancer samples and whether those levels were associated with pathology or prognosis. Additionally, the researchers examined how miR-146a regulates EGFR and IRAK.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.